Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for

M Campins-Martí1, H K Cheng, K Forsyth

  • 1Department of Preventive Medicine and Epidemiology, Vall d'Hebron Hospital, Barcelona, Spain.

Vaccine
|December 12, 2001
PubMed

Insights

Pertussis vaccination protects infants, but adults spread the disease to vulnerable babies. Adult acellular pertussis vaccines offer protection and can reduce transmission.

Area of Science:

  • Immunology
  • Public Health
  • Vaccinology

Background:

  • Infant pertussis vaccination significantly reduced childhood disease and mortality.
  • A substantial public health challenge remains: addressing pertussis (whooping cough) morbidity and economic burden in older populations.
  • Adolescents and adults are key reservoirs for pertussis transmission to unvaccinated or partially vaccinated infants, who are at high risk for severe complications.

Purpose of the Study:

  • To review strategies for extending pertussis (whooping cough) vaccination to older age groups.
  • To evaluate the role of adult-type acellular pertussis vaccines in disease control.
  • To identify optimal immunization programs for adolescents and adults to protect both individuals and vulnerable infants.

Main Methods:

  • Review of existing literature on pertussis epidemiology and vaccination strategies.
  • Analysis of the effectiveness and safety of adult acellular pertussis vaccines.
  • Discussion of various immunization program models, including universal and targeted approaches.

Main Results:

  • Adult-type acellular pertussis vaccines are safe and effective in preventing pertussis.
  • Universal vaccination across all age groups offers the most comprehensive protection but faces logistical and economic challenges.
  • Targeted strategies, such as adolescent boosters and vaccinating adults in close contact with infants, are feasible first steps.

Conclusions:

  • Expanding pertussis vaccination to adolescents and adults is crucial for controlling the disease and protecting infants.
  • A phased approach, starting with adolescent boosters and targeted adult vaccination, is recommended.
  • Country-specific implementation details for pertussis immunization programs are necessary, considering local circumstances.

Related Concept Videos

Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Vaccinations01:51

Vaccinations

Overview
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...